To Örebro University

oru.seÖrebro University Publications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Irritable bowel syndrome: Factors of importance for disease-specific quality of life
Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden; INSERM UMR 1073, Institute for Research and Innovation in Biomedicine, Normandy University, Rouen, France; Gastroenterology Department and INSERM CIC-CRB 1404, Rouen University Hospital, Rouen, France.
Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden; Department of Chronic Diseases, Metabolism and Aging (CHROMETA), Translational Research Center for Gastrointestinal Disorders (TARGID), Leuven, Belgium.
Örebro University, School of Behavioural, Social and Legal Sciences. Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.ORCID iD: 0000-0003-1208-2077
Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Show others and affiliations
2022 (English)In: United European Gastroenterology journal, ISSN 2050-6406, E-ISSN 2050-6414, Vol. 10, no 7, p. 754-764Article in journal (Refereed) Published
Abstract [en]

Background: Irritable bowel syndrome patients report reduced disease-specific quality of life (IBSQOL). Factors of potential relevance for QOL include gastrointestinal (GI), psychological, and somatic symptoms, demographics, and GI motor and sensory abnormalities.

Objective: The aim of our study was to evaluate the relative importance of these factors on the different IBSQOL dimensions.

Methods: We included irritable bowel syndrome (IBS) patients who completed validated questionnaires to assess QOL, stool form and frequency, GI symptom severity, psychological distress, GI-specific anxiety, sense of coherence, and overall somatic symptom severity. Patients also underwent tests for oroanal transit time and rectal sensitivity. The nine dimensions of IBSQOL and their average (overall IBSQOL) were used as outcome variables, and factors associated with these were assessed using general linear models.

Results: We included 314 IBS patients (74% female, mean age 36.3 +/- 12.2 years). Higher stool frequency, GI and overall somatic symptom severity, psychological distress, and GI-specific anxiety were independently associated with reduced overall IBSQOL, with the model explaining 60% of the variance (p < 0.001). In models using each of the nine dimensions as outcomes, different association of demographic factors, GI symptoms, overall somatic symptom severity, psychological factors and sense of coherence were associated with reduced IBSQOL, explaining 20%-60% of the variance, with GI-specific anxiety being the factor that contributed most frequently. Rectal sensitivity or oroanal transit time were not independently associated with any of the dimensions.

Conclusion: Different combinations of demographic factors, GI and somatic symptoms, and psychological factors are of importance for the nine IBSQOL dimensions. Gastrointestinal-specific anxiety was the most important factor contributing to the majority of those dimensions in patients with IBS.

Place, publisher, year, edition, pages
John Wiley & Sons, 2022. Vol. 10, no 7, p. 754-764
Keywords [en]
disease-specific QOL, disease-specific quality of life, factors, IBS, IBSQOL, irritable bowel syndrome, QOL, quality of life
National Category
Gastroenterology and Hepatology
Identifiers
URN: urn:nbn:se:oru:diva-109186DOI: 10.1002/ueg2.12277ISI: 000824622200001Scopus ID: 2-s2.0-85133917057OAI: oai:DiVA.org:oru-109186DiVA, id: diva2:1806150
Funder
Swedish Research Council, 2018–02566
Note

The study was funded by grants from the Swedish state under the agreement between the Swedish government and the county councils, the ALF‐agreement (ALFGBG‐726561, 722331, 875581), the Swedish Research Council (2018–02566), and the Faculty of Medicine at the University of Gothenburg. CM has been awarded the UEG Research Award 2020 for her stay at The University of Gothenburg. Mahrukh Khadija has been awarded Mary von Sydow research award 2021.

Available from: 2023-10-19 Created: 2023-10-19 Last updated: 2023-10-27Bibliographically approved

Open Access in DiVA

No full text in DiVA

Other links

Publisher's full textScopus

Authority records

Trindade, Inês A.

Search in DiVA

By author/editor
Trindade, Inês A.
By organisation
School of Behavioural, Social and Legal Sciences
In the same journal
United European Gastroenterology journal
Gastroenterology and Hepatology

Search outside of DiVA

GoogleGoogle Scholar

doi
urn-nbn

Altmetric score

doi
urn-nbn
Total: 22 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf